Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| ASML Holding | 2.19% | $22.21M | $540.24B | 97.20% | 81 Outperform | |
| Roche Holding AG | 1.26% | $12.81M | CHF294.92B | 46.36% | 73 Outperform | |
| Novartis | 1.25% | $12.72M | $316.32B | 54.69% | 80 Outperform | |
| AstraZeneca | 0.99% | $10.08M | $324.77B | 32.79% | 80 Outperform | |
| Royal Bank Of Canada | 0.96% | $9.74M | $236.25B | 41.64% | 75 Outperform | |
| LVMH Moet Hennessy Louis Vuitton | 0.71% | $7.17M | €262.31B | -23.47% | 78 Outperform | |
| Toyota Motor | 0.70% | $7.11M | ¥48.39T | 35.36% | 80 Outperform | |
| Rolls-Royce Holdings | 0.69% | $6.99M | £109.32B | 121.53% | 71 Outperform | |
| Unilever | 0.64% | $6.54M | $159.29B | 15.70% | 73 Outperform | |
| ― | 0.64% | $6.47M | ― | ― | ― |